Showing results (1-10 of 87) with videos related to
Sort By:
Pageof 9
Virus Genes|July 27, 2017
Reconstructing the immune system with lentiviral vectorsHenning Olbrich, Constanze Slabik, Renata StripeckeHuman Gene Therapy|March 12, 2020
Adult and Cord Blood-Derived High-Affinity gB-CAR-T Cells Effectively React Against Human Cytomegalovirus InfectionsHenning Olbrich, Sebastian J Theobald, Constanze Slabik, et al.Molecular Therapy Oncolytics|September 21, 2020
CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative DiseaseConstanze Slabik, Maja Kalbarczyk, Simon Danisch, et al.Methods in Molecular Biology (Clifton, N.J.)|December 27, 2008
Lentiviral vector-mediated genetic programming of mouse and human dendritic cellsRenata StripeckeBiomedicines|May 27, 2017
Lentivirus-Induced Dendritic Cells (iDC) for Immune-Regenerative Therapies in Cancer and Stem Cell TransplantationRenata StripeckeVaccines|February 22, 2020
Modeling Human Cytomegalovirus in Humanized Mice for Vaccine TestingJohannes Koenig, Sebastian J Theobald, Renata StripeckeExpert Review of Vaccines|March 12, 2010
Lentiviral vectors for immunization: an inflammatory fieldMudita Pincha, Bala Sai Sundarasetty, Renata StripeckeExpert Opinion on Emerging Drugs|August 29, 2025
Emerging drugs for the treatment of bullous pemphigoid: what's new on the horizon?Henning Olbrich, Christian D SadikThe American Journal of Pathology|December 30, 2018
Spatiotemporally Skewed Activation of Programmed Cell Death Receptor 1-Positive T Cells after Epstein-Barr Virus Infection and Tumor Development in Long-Term Fully Humanized MiceSimon Danisch, Constanze Slabik, Angela Cornelius, et al.Expert Opinion on Investigational Drugs|August 1, 2023
Autoimmune blistering diseases: promising agents in clinical trialsHenning Olbrich, Christian D Sadik, Enno SchmidtPageof 9